Advertisement
ISRG vs TRIB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ISRG is a Hold and TRIB is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ISRG’s FA Score shows that 1 FA rating(s) are green whileTRIB’s FA Score has 1 green FA rating(s).
- ISRG’s FA Score: 1 green, 4 red.
- TRIB’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ISRG’s TA Score shows that 5 TA indicator(s) are bullish while TRIB’s TA Score has 4 bullish TA indicator(s).
- ISRG’s TA Score: 5 bullish, 5 bearish.
- TRIB’s TA Score: 4 bullish, 3 bearish.
Price Growth
ISRG (@Pharmaceuticals: Other) experienced а -1.36% price change this week, while TRIB (@Medical/Nursing Services) price change was -7.89% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.03%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +8.18%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.47%. For the same industry, the average monthly price growth was -8.60%, and the average quarterly price growth was +8.79%.
Reported Earning Dates
ISRG is expected to report earnings on Jan 22, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-2.03% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-5.47% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ISRG | TRIB | ISRG / TRIB | |
| Capitalization | 200B | 15.4M | 1,298,701% |
| EBITDA | 3.4B | -16.91M | -20,095% |
| Gain YTD | 8.177 | -81.163 | -10% |
| P/E Ratio | 74.69 | 0.56 | 13,285% |
| Revenue | 9.61B | 61.6M | 15,604% |
| Total Cash | 4.91B | 5.17M | 95,007% |
| Total Debt | 87M | 101M | 86% |
ISRG | TRIB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 86 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | 49 Fair valued | |
PROFIT vs RISK RATING 1..100 | 26 | 100 | |
SMR RATING 1..100 | 50 | 100 | |
PRICE GROWTH RATING 1..100 | 44 | 97 | |
P/E GROWTH RATING 1..100 | 60 | 13 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TRIB's Valuation (49) in the Medical Specialties industry is somewhat better than the same rating for ISRG (91). This means that TRIB’s stock grew somewhat faster than ISRG’s over the last 12 months.
ISRG's Profit vs Risk Rating (26) in the Medical Specialties industry is significantly better than the same rating for TRIB (100). This means that ISRG’s stock grew significantly faster than TRIB’s over the last 12 months.
ISRG's SMR Rating (50) in the Medical Specialties industry is somewhat better than the same rating for TRIB (100). This means that ISRG’s stock grew somewhat faster than TRIB’s over the last 12 months.
ISRG's Price Growth Rating (44) in the Medical Specialties industry is somewhat better than the same rating for TRIB (97). This means that ISRG’s stock grew somewhat faster than TRIB’s over the last 12 months.
TRIB's P/E Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for ISRG (60). This means that TRIB’s stock grew somewhat faster than ISRG’s over the last 12 months.
| ISRG | TRIB | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 42% | 1 day ago 78% |
| Stochastic ODDS (%) | 1 day ago 63% | 1 day ago 86% |
| Momentum ODDS (%) | 1 day ago 79% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 61% | N/A |
| TrendWeek ODDS (%) | 1 day ago 61% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 65% | 1 day ago 90% |
| Advances ODDS (%) | 1 day ago 70% | 1 day ago 80% |
| Declines ODDS (%) | 4 days ago 58% | 8 days ago 89% |
| BollingerBands ODDS (%) | 1 day ago 43% | 1 day ago 81% |
| Aroon ODDS (%) | 1 day ago 67% | 1 day ago 88% |
Advertisement
TRIB and
Correlation & Price change
A.I.dvisor indicates that over the last year, TRIB has been loosely correlated with VAPO. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if TRIB jumps, then VAPO could also see price increases.
| Ticker / NAME | Correlation To TRIB | 1D Price Change % | ||
|---|---|---|---|---|
| TRIB | 100% | +0.69% | ||
| VAPO - TRIB | 34% Loosely correlated | N/A | ||
| RGEN - TRIB | 28% Poorly correlated | +1.31% | ||
| NVCR - TRIB | 26% Poorly correlated | +0.09% | ||
| SERA - TRIB | 23% Poorly correlated | +2.56% | ||
| COO - TRIB | 23% Poorly correlated | -0.06% | ||
More | ||||